AURO LABORATORIES
Back to Balance Sheet
|
AURO LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹34 Cr | ₹20 Cr | ₹3.66 Cr | ₹3.31 Cr | ₹4.08 Cr |
What is the latest Total Non-Current Liabilities ratio of AURO LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹34 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹3.66 Cr |
| Mar2022 | ₹3.31 Cr |
| Mar2021 | ₹4.08 Cr |
How is Total Non-Current Liabilities of AURO LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹34 Cr | 73.83 | |
| Mar2024 | ₹20 Cr | 441.63 | |
| Mar2023 | ₹3.66 Cr | 10.70 | |
| Mar2022 | ₹3.31 Cr | -18.80 | |
| Mar2021 | ₹4.08 Cr | - | |
Compare Total Non-Current Liabilities of peers of AURO LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AURO LABORATORIES | ₹152.5 Cr | 5.9% | 1.1% | -6.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,559.0 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,827.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,942.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹106,825.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,077.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
AURO LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AURO LABORATORIES | 5.9% |
1.1% |
-6.1% |
| SENSEX | 1.7% |
-1.7% |
10.3% |
You may also like the below Video Courses